Triamcinolone Acetonide: Glucocorticoid in Therapy
Triamcinolone acetonide (trade names Volon A, Triamhexal and generics) is a synthetic glucocorticoid with high potency. The acetonide form has only weak water solubility and is particularly suitable for depot applications. The substance is used topically in ointments and creams, intralesionally for localized skin changes, intra-articularly for joint inflammation, and in specialized settings intravitreally in ophthalmology. Systemic therapy with triamcinolone is possible but in practice is usually reserved for other glucocorticoids such as prednisolone or methylprednisolone.
Triamcinolone acetonide has become particularly established in dermatology and rheumatology. In general practice, the drug is a classic for the treatment of chronic plaque psoriasis and eczematous skin diseases. In rheumatology, intra-articular injection is used for activated arthrosis, bursitis, and enthesopathies. Physicians prescribing or using this medication should be aware of the typical risks of topical and intralesional steroids, particularly skin atrophy, hypopigmentation, and infection risks.
Mechanism of Action
Like all glucocorticoids, triamcinolone acetonide binds to the intracellular glucocorticoid receptor. The activated receptor translocates to the cell nucleus and influences gene expression. The anti-inflammatory effect is based on the inhibition of pro-inflammatory mediators such as cytokines, chemokines, prostaglandins, and leukotrienes as well as the induction of anti-inflammatory proteins such as annexin 1.
Triamcinolone acetonide has approximately five times more anti-inflammatory activity than hydrocortisone and no relevant mineralocorticoid activity, so salt retention is minimal. The long duration of action of the acetonide form is based on its poor water solubility, which allows the substance to be released slowly from the depot after local injection. Intra-articular administration exerts its effect over weeks to months.
Topically, triamcinolone acetonide demonstrates moderate potency (Class II according to European classification). The effect occurs rapidly in acute skin reactions, with maintenance therapy over weeks being common. Absorption through intact skin is minimal, but through inflamed or occluded skin and over large areas it can become systemically relevant.
Indications
- Topical: inflammatory and pruritic skin diseases such as plaque psoriasis, atopic dermatitis, allergic and toxic contact eczema, lichen simplex chronicus, lichen planus.
- Intralesional: keloids, hypertrophic scars, granuloma annulare, lichen planus, alopecia areata, acne conglobata with large nodules.
- Intra-articular and periarticular: activated osteoarthritis, rheumatoid arthritis with locally active joint, tenosynovitis, bursitis, carpal tunnel syndrome.
- Intravitreal in specialized ophthalmology for diabetic maculopathy, uveitis, macular edema.
- Systemic rarely, rather in acute allergic reactions, acute asthma exacerbation or other indications when other glucocorticoids are unavailable.
Triamcinolone acetonide is not an emergency medication for anaphylaxis. In acute anaphylaxis, intramuscular epinephrine takes priority, supplemented by intravenous glucocorticoids such as prednisolone.
Dosage and Administration
Topical: 0.1% cream or ointment applied one to two times daily to the affected area in a thin layer. Duration of therapy typically maximum two weeks without dermatologist contact. For chronic skin diseases, use in pulse regimen or in combination with non-steroid topicals.
Intralesional: 5 to 10 mg per ml diluted in 0.9% saline, depending on the lesion 0.1 to 1 ml per injection. Repeat every two to four weeks, maximum three to four sessions.
Intra-articular: for large joints (knee) 20 to 40 mg, medium-sized joints (shoulder, elbow) 10 to 20 mg, small joints (fingers, toes) 2 to 5 mg. Repeat not before three months, maximum three to four injections per year and joint.
Intravitreal only by experienced ophthalmologist in specialized clinic, individual dosage, risk of endophthalmitis and lens opacification.
Renal insufficiency and hepatic insufficiency: with systemic use adjust dose individually because hepatic metabolism is reduced.
Topical application: thin layer, non-occlusive (except on medical instruction), not over large areas of inflamed skin or in children over wide areas.
Adverse Effects
Topical: skin atrophy, telangiectasias, perioral dermatitis, striae, pigment changes, acne, folliculitis, impaired wound healing, secondary bacterial or fungal infections.
Intralesional: local atrophy, hypopigmentation (particularly visible in darker skin), telangiectasias, steroid crystal deposits, localized pain, in rare cases pigment lines along lymphatic vessels.
Intra-articular: post-injection flare with transient worsening of pain over 24 to 48 hours, skin redness, subcutaneous atrophy, very rarely septic arthritis. Frequent injections can promote cartilage damage.
Systemic (also possible with extensive topical or frequent intralesional use): Cushing syndrome, diabetes mellitus, osteoporosis, muscle wasting, glaucoma, cataract, mood swings, sleep disorders, suppression of the hypothalamic-pituitary-adrenal axis.
Eye: intravitreal increase in intraocular pressure, cataract formation, endophthalmitis, retinal damage in rare cases.
Anaphylaxis to excipients very rare, especially with intra-articular use.
Drug Interactions
- NSAIDs and anticoagulants: increased risk of gastrointestinal bleeding with systemic use.
- Antidiabetic agents: steroids can increase insulin resistance, monitor blood glucose closely.
- Potassium-wasting diuretics (loop diuretics, thiazides): hypokalemia, especially with systemic steroid use.
- CYP3A4 inhibitors (itraconazole, ketoconazole, ritonavir, erythromycin, clarithromycin): elevated triamcinolone levels with systemic or frequent local use, increased Cushing risk.
- CYP3A4 inducers (rifampicin, phenytoin, carbamazepine): reduced effect of steroids.
- Live vaccines contraindicated with systemic or high-dose steroid therapy due to immunosuppression.
- Local antifungals and antibiotics: combination products possible, adhere strictly to indication.
Special Notes
Pregnancy: topical use in limited application possible, especially on small skin areas and non-occlusive. Extensive or prolonged use should be avoided. Intra-articular use possible in individual indications. Breastfeeding: with topical use outside the nipple and in small amounts possible, do not apply directly on the breast before nursing.
Children: only with low potency and on small skin areas, not extensively or occlusively. In the face and intertriginous areas very restrictively. In infants, thin skin leads to higher absorption.
Elderly patients: increased risks for skin atrophy, wound healing disorders, and bone metabolism changes, regular re-evaluation important.
Before intra-articular injection: exclude acute joint infection (history, clinical presentation, possibly aspiration). Sterile conditions, counseling on post-injection flare and management of symptoms such as fever or increasing swelling.
Ophthalmology: intravitreal therapy only in specialized centers with capability for intraocular pressure measurement, slit-lamp examination, and endophthalmitis management.
Lifestyle: with systemic or extensive therapy calorie, salt, and sugar-conscious diet, physical activity for bone health, vitamin D and calcium, protection against infections.
Driving ability: not affected by topical and intralesional use. With systemic use to be evaluated individually.
You Might Also Be Interested In
- Dexamethasone, high-potency glucocorticoid in oncology and emergency medicine
- Prednisolone, classic systemic glucocorticoid
- Methylprednisolone, intermediate potency steroid
- Budesonide, inhaled or oral glucocorticoid
- Clobetasol, high-potency topical steroid
Frequently Asked Questions
How long may I use triamcinolone ointment?
On a small skin area, one to two weeks are typical. For chronic skin diseases, individual schedules with pulse therapy or weekend application are suitable, always under dermatologic supervision. Overly prolonged unguided application can cause skin atrophy and striae.
What happens with too frequent intra-articular injection?
Repeated steroid injections can damage cartilage long-term, weaken ligaments, and increase the risk of septic arthritis. In practice, a maximum of three to four injections per year and joint are performed. For more frequent flares, alternatives such as structured physiotherapy, intra-articular hyaluronic acid, or surgical options should be considered.
May I use triamcinolone cream on my face?
On the face, the skin is thin and reacts sensitively to medium-potency steroids. Application should be very restrictive, short-term, and not without dermatologic instruction. Perioral dermatitis and steroid acne are typical consequences of prolonged facial use.
What is a post-injection flare?
After intra-articular steroid injection, pain and swelling can temporarily increase in the first 24 to 48 hours. The cause is steroid crystals triggering an inflammatory reaction. Cooling and short-term analgesics help. With persistent complaints, fever, or redness, septic arthritis must be medically ruled out.
Sources
- Gelbe Liste, Triamcinolone Acetonide Active Ingredient Profile
- BfArM, Federal Institute for Drugs and Medical Devices
- AWMF, Guidelines for Psoriasis, Atopic Dermatitis and Osteoarthritis
- EMA, European Medicines Agency
Legal Notes and Disclaimer
The information provided on this page is for general information purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. It does not replace the advice of a licensed physician or pharmacist. Medications should only be taken on medical prescription or by pharmacy dispensing. All information is based on specialist information published at the time of creation and recognized scientific sources, with the current product information from the manufacturer always being authoritative. Sanoliste assumes no liability for completeness, currency, or accuracy of the information presented. In a medical emergency, call the emergency number 112.